TY  - RPRT
TI  - Safety, Pharmacokinetics, and Pharmacodynamics of Single-Dose Programmed Cell Death Protein 1 Inhibitor, Budigalimab, in People With HIV-1 With Antiretroviral Therapy-Suppressed Viral Load.
AU  - Tanaya R Vaidya
AU  - Till Geib
AU  - Jacob P Lalezari
AU  - Christopher Bettacchi
AU  - Cynthia C Brinson
AU  - Peter J Ruane
AU  - Heide Betman
AU  - Fei Zhou
AU  - Preethi Krishnan
AU  - Nael M Mostafa
PY  - 2026
DO  - 10.1093/infdis/jiag142
UR  - https://pubmed.ncbi.nlm.nih.gov/41955081/
ID  - 41955081
ER  -